Donna Ansari lives in New York City with her family. In her professional life, she works in the pharmaceutical advertising sector, contributing to both HCP and DTC facing materials. Donna was diagnosed with thyroid eye disease (TED) in 2024 and joined the SatraGO Phase 3 clinical trial later that year. She is currently Vice President of Northwell’s Clinical Trial Participant Advisory Board.
